Dr. Zaineb Akram
Clinical trials sponsored by Dr. Zaineb Akram, explained in plain language.
-
Engineered immune cells take aim at Hard-to-Treat childhood leukemia
Disease control Recruiting nowThis trial investigates a personalized cell therapy called CAR-T for children and young adults (ages 5–50) with B-cell acute lymphoblastic leukemia that has relapsed or not responded to standard treatment. The therapy involves collecting a patient's own immune cells, engineering …
Phase: EARLY_PHASE1 • Sponsor: Dr. Zaineb Akram • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Engineered immune cells take on incurable blood cancer
Disease control Recruiting nowThis trial investigates a personalized cell therapy called CAR-T, which reprograms a patient's own immune cells to recognize and attack a protein (BCMA) on multiple myeloma cells. The study enrolls 10 adults whose cancer has returned or become resistant after at least three prior…
Phase: PHASE2 • Sponsor: Dr. Zaineb Akram • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC